Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside Byung-Sik Cho et al, 2017, Korean J Intern Med CrossRef
Evidence that high-migration drug-surviving MOLT4 leukemia cells exhibit cancer stem cell-like properties XIAOXING HUANG et al, 2016 CrossRef
Sinomenine prevents metastasis of human osteosarcoma cells via S phase arrest and suppression of tumor-related neovascularization and osteolysis through the CXCR4-STAT3 pathway TAO XIE et al, 2016 CrossRef
Enhanced Anti-Leukemic Effects through Induction of Immunomodulating Microenvironment by Blocking CXCR4 and PD-L1 in an AML Mouse Model Hee-Sun Hwang et al, 2018, Immunological Investigations CrossRef
Mobilization of leukemic cells using plerixafor as part of a myeloablative preparative regimen for patients with AML undergoing allografting: assessment of safety and tolerability Fotios V. Michelis et al, 2019, Biology of Blood and Marrow Transplantation CrossRef
Suppression of Breast Cancer Cell Migration by Small Interfering RNA Delivered by Polyethylenimine-Functionalized Graphene Oxide Yuan-Pin Huang et al, 2016, Nanoscale Res Lett CrossRef
Impact of CXCR4/CXCL12 Blockade on Normal Plasma CellsIn Vivo N. Moore et al, 2017, Am J Transplant CrossRef
VLA-4 phosphorylation during tumor and immune cell migration relies on its coupling to VEGFR2 and CXCR4 by syndecan-1. Oisun Jung et al, 2019, J Cell Sci CrossRef
TUG1 Promoted Tumor Progression by Sponging miR-335-5p and Regulating CXCR4-Mediated Infiltration of Pro-Tumor Immunocytes in CTNNB1-Mutated Hepatoblastoma
Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and clinical studies Harinad Maganti et al, 2020, Leukemia Research CrossRef
Targeting CXCR4 in AML and ALL Daniel Cancilla et al, 2020, Front. Oncol. CrossRef
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma Irene M. Ghobrial et al, 2020, Clin Cancer Res CrossRef
Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease Farid Boulad et al, 2021, Blood Cells, Molecules, and Diseases CrossRef
The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies Mahdieh Mehrpouri, 2022, European Journal of Pharmacology CrossRef
Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia Kathryn A. Skelding et al, 2022, IJMS CrossRef
Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance Katerina E. Miari et al, 2023, British J Pharmacology CrossRef
Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia Anna J. Slezak et al, 2024 CrossRef